Biocontrol Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocontrol Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Craig Slotoroff who wrote ()	12/18/1996 11:31:00 AM
From: Michael Kaufman	of 100

To All. BICO PR Relase 12/18. PITTSBURGH, Dec. 18 /PRNewswire/ -- Biocontrol Technology Inc announced today that the Company is continuing discussions with senior officials at the Food and Drug Administration (FDA) on the recently submitted in-home testing protocol for its Diasensor 1000(TM) noninvasive glucose sensor for diabetics. In addition, the Company said that it is moving ahead with screening and enrollment of applicants to participate in the study, which it anticipates beginning in early January. Biocontrol Technology, Inc. has its corporate offices in Pittsburgh, PA and is involved in the development and manufacture of biomedical devices and environmental products. SOURCE Biocontrol Technology, Inc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next